Dr. Alexander Menter
Claim this profileKaiser Permanente-Franklin
Expert in Cancer
Studies Lung Cancer
30 reported clinical trials
73 drugs studied
About Alexander Menter
Education:
- Obtained a Medical Degree (MD) from the University of Colorado School of Medicine in 2015.
- Completed a Residency in Internal Medicine at the University of Colorado Hospital in 2018.
- Finished a Fellowship in Hematology/Oncology at the University of Colorado Anschutz Medical Campus in 2021.
Experience:
- Currently practices as a Hematologist/Oncologist at Kaiser Permanente Lone Tree Medical Offices.
Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage I
2Lung Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Alexander Menter is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
More about Alexander Menter
Clinical Trial Related5 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Alexander Menter has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Bevacizumab
- Biospecimen Collection
- Atezolizumab
Breakdown of trials Alexander Menter has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander Menter specialize in?
Alexander Menter focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is Alexander Menter currently recruiting for clinical trials?
Yes, Alexander Menter is currently recruiting for 15 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Alexander Menter has studied deeply?
Yes, Alexander Menter has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Alexander Menter?
Apply for one of the trials that Alexander Menter is conducting.
What is the office address of Alexander Menter?
The office of Alexander Menter is located at: Kaiser Permanente-Franklin, Denver, Colorado 80205 United States. This is the address for their practice at the Kaiser Permanente-Franklin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.